Ophthalmology · Amarillo, TX
NPI
1235107590
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
7411 Wallace Blvd
Amarillo, TX, 79106
Phone (806) 350-1100
Groups this clinician bills Medicare through
Medicare paid, 2024
$532K
9,596 services
Medicare patients, 2024
1,198
Average age 77
Drug cost, 2024
$1.2M
8,381 prescriptions
Company payments, 2025
$579
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amber A Dobler-Dixon was code 99214 (office e&m - established), 2,477 times for 1,122 patients. In total Amber A Dobler-Dixon billed 9,596 services in 33 codes, and Medicare paid $532K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-08-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,477 | 1,122 | $86.60 | $215K |
| 92145 Test - Miscellaneous | Office | 1,504 | 916 | $7.86 | $12K |
| 92020 Ophthalmological E&M | Office | 1,141 | 1,031 | $18.01 | $21K |
| 92083 Vision, Hearing, and Speech Services | Office | 1,135 | 781 | $32.23 | $37K |
| 92133 Computerized Ophthalmic Imaging | Office | 1,041 | 926 | $24.01 | $25K |
| 92250 Angiography | Office | 728 | 713 | $23.71 | $17K |
| 99213 Office E&M - Established | Office | 549 | 438 | $63.39 | $35K |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 432 | 286 | $174.89 | $76K |
| 92014 Ophthalmological E&M | Office | 241 | 238 | $44.84 | $11K |
| 76514 Ultrasound - Nonspecific | Office | 112 | 112 | $7.67 | $859 |
| 99204 Office E&M - New | Office | 48 | 48 | $104.75 | $5,028 |
| 66183 Fluid Flow and Drainage of Eye (Any Method) | Facility | 33 | 30 | $774.21 | $26K |
| 66172 Fluid Flow and Drainage of Eye (Any Method) | Facility | 20 | 20 | $896.78 | $18K |
| 66250 Eye | Facility | 16 | 15 | $419.84 | $6,717 |
| 66821 Cataract Surgery | Office | 12 | 12 | $247.83 | $2,974 |
By year: 2022 $579K for 9,876 services; 2023 $581K for 9,656 services; 2024 $532K for 9,596 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amber A Dobler-Dixon prescribed most often to Medicare patients was Dorzolamide Hcl, with 990 prescriptions and refills. In total Amber A Dobler-Dixon wrote 8,381 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dorzolamide Hcl Generic | 990 | 1,858 | 289 | $19K |
| Brimonidine Tartrate Generic | 900 | 1,514 | 238 | $19K |
| Latanoprost Generic | 880 | 1,682 | 244 | $7,249 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 802 | 1,561 | 212 | $13K |
| Timolol Maleate Generic | 646 | 1,042 | 151 | $12K |
| Lumigan Bimatoprost | 605 | 1,013 | 141 | $244K |
| Rhopressa Netarsudil Mesylate | 568 | 847 | 147 | $253K |
| Prednisolone Acetate Generic | 441 | 681 | 169 | $21K |
| Combigan Brimonidine Tartrate/Timolol | 307 | 483 | 77 | $92K |
| Ofloxacin Generic | 238 | 257 | 112 | $3,176 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 217 | 335 | 49 | $23K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 209 | 326 | 56 | $104K |
| Alphagan P Brimonidine Tartrate | 190 | 264 | 45 | $63K |
| Simbrinza Brinzolamide/Brimonidine Tart | 185 | 231 | 29 | $39K |
| Besivance Besifloxacin Hcl | 170 | 181 | 85 | $40K |
Brand drugs: - claims; generic drugs: 4,650 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amber A Dobler-Dixon $579 ($579 in general payments such as food, travel and fees) from 5 companies. The largest payer was Abbvie Inc. with $253.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.